Glucose Com Cloreto De Sodio Paracelsia

Glucose Com Cloreto De Sodio Paracelsia is an injectable solution containing sodium chloride and glucose. It is supplied as an intravenous fluid without a specified strength, intended for clinical use in the European market. The combination provides isotonic fluid, electrolytes, and a carbohydrate source to support fluid balance and energy needs during medical treatment. It is administered under medical supervision and is classified as a prescription‑only product.

Glucose Com Cloreto De Sodio Paracelsia is used in hospital settings for several therapeutic purposes related to fluid and electrolyte management.

- Fluid resuscitation in patients with hypovolemia or blood loss. - Replacement of sodium chloride to correct electrolyte deficits. - Provision of glucose to prevent or treat hypoglycemia. - Adjunct to parenteral nutrition as a source of carbohydrate. - Maintenance of intravascular volume during surgery or critical illness. - Support of renal perfusion in acute kidney injury.

Side effects associated with intravenous administration of Glucose Com Cloreto De Sodio Paracelsia are generally related to the solution’s composition and infusion rate.

Common: - Mild hyperglycemia. - Local irritation at the infusion site. - Transient electrolyte imbalance, such as mild hypernatremia. - Fluid overload in patients with compromised cardiac function.

Serious: - Severe hyperglycemia. - Significant hypernatremia. - Pulmonary edema from fluid overload. - Allergic reaction or anaphylaxis.

Clinicians should consider several precautions before prescribing Glucose Com Cloreto De Sodio Paracelsia to ensure safe use.

- Assess fluid status and cardiac function to avoid overload. - Monitor blood glucose levels, especially in diabetic patients. - Check serum electrolytes prior to and during therapy. - Use caution in patients with renal impairment. - Adjust infusion rate in neonates and pediatric patients. - Avoid rapid infusion in patients at risk of pulmonary edema.

Glucose Com Cloreto De Sodio Paracelsia may interact with other medications or solutions administered intravenously.

Avoid: - Co‑administration with hypertonic saline solutions, which can cause severe electrolyte disturbances. - Simultaneous infusion of large volumes of dextrose‑containing fluids in patients at risk of hyperglycemia. - Use with drugs that require strict fluid restriction, such as certain diuretics, without adjusting volume.

Use with caution: - Concurrent use of insulin therapy; monitor glucose closely. - Administration with nephrotoxic agents; monitor renal function and fluid balance. - Combination with other electrolyte solutions; adjust sodium load as needed.